Neuroinflammation PET imaging of the translocator protein (TSPO) in Alzheimer's disease: An update
The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Neuroinflammation is a significant contributor to Alzheimer's disease (AD). Until now, PET imaging of the translocator protein (TSPO) has been widely used to depict the neuroimmune endophenotype of AD. The aim of this review was to provide an update to the results from 2018 and to advance the characterization of the biological basis of TSPO imaging in AD by re‐examining TSPO function and expression and the methodological aspects of interest. Although the biological basis of the TSPO PET signal is obviously related to microglia and astrocytes in AD, the observed process remains uncertain and might not be directly related to neuroinflammation. Further studies are required to re‐examine the cellular significance underlying a variation in the PET signal in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 2×
“While the cerebellum appears to be spared from AD pathological changes in the earliest stages (Braak & Braak, 1991; Thal et al., 2002), a few neuropathological studies have revealed the presence of amyloid angiopathy and diffuse amyloid plaques in the cerebellar cortex of AD patients with dementia,…”
BackgroundMethodNeuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
Leng, F., & Edison, P. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-020-00435-y · Cited by 3,179 · cited 3×
“These results support a stage-dependent model of neuroinflammation with a biphasic change, in accordance with transsectional TSPO PET studies and with neuropathological and mechanistic preclinical data (Leng & Edison, 2021).”
BackgroundResultReactive astrocyte nomenclature, definitions, and future directions
Escartin, C., Galea, E., Lakatos, A., O’Callaghan, J. P., Petzold, G. C., Serrano-Pozo, A., Steinhäuser, C., Volterra, A., Carmignoto, G., Agarwal, A., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00783-4 · Cited by 2,513 · cited 1×
“This heterogeneity goes beyond the simplified polarizing scheme of neuroprotective and neuro-toxic functions in AD (Escartin et al., 2021; Murray et al., 2014; Ransohoff, 2016).”
BackgroundA polarizing question: do M1 and M2 microglia exist?
Ransohoff, R. M. (2016) · Nature Neuroscience · doi:10.1038/nn.4338 · Cited by 1,573
Neural mechanisms of ageing and cognitive decline
Bishop, N. A., Lu, T., & Yankner, B. A. (2010) · Nature · doi:10.1038/nature08983 · Cited by 1,323 · cited 1×
“One major concern in the understanding of microglial and astrocyte function in AD lies in inter-species divergences in terms of genetics, morphology, function, and pharmacology (Arranz & De Strooper, 2019; Bishop et al., 2010; Smith & Dragunow, 2014).”
BackgroundSpatial and temporal heterogeneity of mouse and human microglia at single-cell resolution
Masuda, T., Sankowski, R., Staszewski, O., Böttcher, C., Amann, L., Sagar, Scheiwe, C., Nessler, S., Kunz, P., van Loo, G., et al. (2019) · Nature · doi:10.1038/s41586-019-0924-x · Cited by 1,310
Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease
Kisler, K., Nelson, A. R., Montagne, A., & Zlokovic, B. V. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.48 · Cited by 1,243
Synergy between amyloid-β and tau in Alzheimer’s disease
Busche, M. A., & Hyman, B. T. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0687-6 · Cited by 1,242
In-vivo measurement of activated microglia in dementia
Cagnin, A., Brooks, D. J., Kennedy, A. M., Gunn, R. N., Myers, R., Turkheimer, F. E., Jones, T., & Banati, R. B. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05625-2 · Cited by 1,054 · cited 1×
“This issue would be even more problematic in TSPO imaging studies where AD biomarkers are not used (Cagnin et al., 2001; Golla et al., 2015, 2016; Kreisl et al., 2013), as the absence of AD pathophysiology in the brain would certainly impact the immune response.”
BackgroundOwen, D. R., Yeo, A. J., Gunn, R. N., Song, K., Wadsworth, G., Lewis, A., Rhodes, C., Pulford, D. J., Bennacef, I., Parker, C. A., et al. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.147 · Cited by 779
The role of microglia in amyloid clearance from the AD brain
Lee, C. Y. D., & Landreth, G. E. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0433-4 · Cited by 701 · cited 1×
“…of PET studies, for example, if tangle-associated microglia exhibit a pro-inflammatory phenotype in the medial temporal structures (Sanchez-Mejias et al., 2016), while plaqueassociated microglia exert a neuroprotective role on amyloid clearance in other regions (Lee & Landreth, 2010).”
BackgroundImaging the evolution and pathophysiology of Alzheimer disease
Jagust, W. (2018) · Nature Reviews Neuroscience · doi:10.1038/s41583-018-0067-3 · Cited by 604 · cited 1×
“…AD brain lesions follows different trajectories according to disease stage and to the different subtypes of AD (e.g., monogenic or sporadic forms with early or late symptom onset) (Jagust, 2018), and the TSPO PET imaging pattern may also be dependent on the pathological context at a regional level.”
BackgroundHamelin, L., Lagarde, J., Dorothée, G., Leroy, C., Labit, M., Comley, R. A., de Souza, L. C., Corne, H., Dauphinot, L., Bertoux, M., et al. (2016) · Brain · doi:10.1093/brain/aww017 · Cited by 519
Microglial activation and tau propagate jointly across Braak stages
Pascoal, T. A., Benedet, A. L., Ashton, N. J., Kang, M. S., Therriault, J., Chamoun, M., Savard, M., Lussier, F. Z., Tissot, C., Karikari, T. K., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01456-w · Cited by 490
Reactive Glia not only Associates with Plaques but also Parallels Tangles in Alzheimer’s Disease
Serrano-Pozo, A., Mielke, M. L., Gómez-Isla, T., Betensky, R. A., Growdon, J. H., Frosch, M. P., & Hyman, B. T. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.047 · Cited by 488 · cited 1×
“Neuropathological studies have highlighted that microglial and astrocyte activation increases with the severity of neuritic plaques and neurofibrillary tangles, with variation according to the brain regions involved (Serrano-Pozo et al., 2011; Xiang et al., 2006).”
BackgroundCosenza‐Nashat, M., Zhao, M. ‐., Suh, H. ‐., Morgan, J., Natividad, R., Morgello, S., & Lee, S. C. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01006.x · Cited by 459 · cited 5×
“TSPO-positive peripheral infiltrating macrophages have also been observed (Cosenza-Nashat et al., 2009; Tomasi et al., 2008; Veronese et al., 2018).”
BackgroundInfluentialMicroglial activation and amyloid deposition in mild cognitive impairment: A PET study
Okello, A., Edison, P., Archer, H. A., Turkheimer, F. E., Kennedy, J., Bullock, R., Walker, Z., Kennedy, A., Fox, N., Rossor, M., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000338622.27876.0d · Cited by 367
A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease
Hampel, H., Caraci, F., Cuello, A. C., Caruso, G., Nisticò, R., Corbo, M., Baldacci, F., Toschi, N., Garaci, F., Chiesa, P. A., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00456 · Cited by 360 · cited 1×
“These results have driven the development of biomarkers to improve our understanding of AD neuroimmune changes and to monitor the engagement of inflammatory treatments (Gyengesi & Münch, 2020; Hampel et al., 2020).”
BackgroundIn vivo radioligand binding to translocator protein correlates with severity of Alzheimer’s disease
Kreisl, W. C., Lyoo, C. H., McGwier, M., Snow, J., Jenko, K. J., Kimura, N., Corona, W., Morse, C. L., Zoghbi, S. S., Pike, V. W., et al. (2013) · Brain · doi:10.1093/brain/awt145 · Cited by 350 · cited 2×
“The statistical significance is not always reached to differentiate these groups (Fan, Aman, et al., 2015; Golla et al., 2015; Guly as et al., 2011; Knezevic et al., 2018; Kreisl et al., 2013; Schuitemaker et al., 2013; Wiley et al., 2009).”
BackgroundMicroglia actions in Alzheimer's disease
Prokop, S., Miller, K. R., & Heppner, F. L. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1182-x · Cited by 291 · cited 1×
“2022;55:1322–1343.wileyonlinelibrary.com/journal/ejn Prokop et al., 2013).”
Microglial activation correlates in vivo with both tau and amyloid in Alzheimer’s disease
Dani, M., Wood, M., Mizoguchi, R., Fan, Z., Walker, Z., Morgan, R., Hinz, R., Biju, M., Kuruvilla, T., Brooks, D. J., et al. (2018) · Brain · doi:10.1093/brain/awy188 · Cited by 270
Smith, A. M., & Dragunow, M. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2013.12.001 · Cited by 256 · cited 1×
“One major concern in the understanding of microglial and astrocyte function in AD lies in inter-species divergences in terms of genetics, morphology, function, and pharmacology (Arranz & De Strooper, 2019; Bishop et al., 2010; Smith & Dragunow, 2014).”
BackgroundPositron emission tomography and functional characterization of a complete PBR/TSPO knockout
Banati, R. B., Middleton, R. J., Chan, R., Hatty, C. R., Wai-Ying Kam, W., Quin, C., Graeber, M. B., Parmar, A., Zahra, D., Callaghan, P., et al. (2014) · Nature Communications · doi:10.1038/ncomms6452 · Cited by 241
The methodology of TSPO imaging with positron emission tomography
Turkheimer, F. E., Rizzo, G., Bloomfield, P. S., Howes, O., Zanotti-Fregonara, P., Bertoldo, A., & Veronese, M. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150058 · Cited by 238 · cited 3×
“As suggested by Turkheimer and colleagues (Turkheimer et al., 2015), this leads to the paradoxical notion that the higher the affinity for TSPO, the higher off-target binding will be.”
BackgroundKuhlmann, A. C., & Guilarte, T. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741694.x · Cited by 215
Fan, Z., Aman, Y., Ahmed, I., Chetelat, G., Landeau, B., Ray Chaudhuri, K., Brooks, D. J., & Edison, P. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.06.016 · Cited by 212
Parbo, P., Ismail, R., Hansen, K. V., Amidi, A., Mårup, F. H., Gottrup, H., Brændgaard, H., Eriksson, B. O., Eskildsen, S. F., Lund, T. E., et al. (2017) · Brain · doi:10.1093/brain/awx120 · Cited by 199 · cited 2×
“For example, Parbo and colleagues observed that the clusters where the correlations of [11C]-PK11195 binding with amyloid deposits on PET occur are not necessarily colocalized with the highest neuroinflammatory signal (Parbo et al., 2017).”
BackgroundOwen, D. R., Narayan, N., Wells, L., Healy, L., Smyth, E., Rabiner, E. A., Galloway, D., Williams, J. B., Lehr, J., Mandhair, H., et al. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17710182 · Cited by 194 · cited 2×
“…have shown that pro-inflammatory stimulation elicits a nine-fold increase in tspo mRNA levels in rodentderived macrophages and microglia, but unchanged tspo mRNA levels in human microglia and a decrease in tspo mRNA levels and binding site abundance in human macrophages (Owen et al., 2017).”
BackgroundMicroglial activation and tau burden predict cognitive decline in Alzheimer’s disease
Malpetti, M., Kievit, R. A., Passamonti, L., Jones, P. S., Tsvetanov, K. A., Rittman, T., Mak, E., Nicastro, N., Bevan-Jones, W. R., Su, L., et al. (2020) · Brain · doi:10.1093/brain/awaa088 · Cited by 194 · cited 2×
“A recent study using [(11)C]-PK11195 showed that an increase in tracer uptake at baseline predicts subsequent cognitive decline among AD patients with MCI or dementia (Malpetti et al., 2020), whereas, in another study, the patients with the highest [(18)F]-DPA714 uptake at baseline had the lowest cognitive decline (Ha…”
ResultCellular sources of TSPO expression in healthy and diseased brain
Nutma, E., Ceyzériat, K., Amor, S., Tsartsalis, S., Millet, P., Owen, D. R., Papadopoulos, V., & Tournier, B. B. (2021) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-020-05166-2 · Cited by 192
Soluble phospho-tau from Alzheimer’s disease hippocampus drives microglial degeneration
Sanchez-Mejias, E., Navarro, V., Jimenez, S., Sanchez-Mico, M., Sanchez-Varo, R., Nuñez-Diaz, C., Trujillo-Estrada, L., Davila, J. C., Vizuete, M., Gutierrez, A., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1630-5 · Cited by 175
Yokokura, M., Mori, N., Yagi, S., Yoshikawa, E., Kikuchi, M., Yoshihara, Y., Wakuda, T., Sugihara, G., Takebayashi, K., Suda, S., et al. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1612-0 · Cited by 174
Ji, B., Maeda, J., Sawada, M., Ono, M., Okauchi, T., Inaji, M., Zhang, M.-R., Suzuki, K., Ando, K., Staufenbiel, M., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2312-08.2008 · Cited by 169
A Phenotypic Change But Not Proliferation Underlies Glial Responses in Alzheimer Disease
Serrano-Pozo, A., Gómez-Isla, T., Growdon, J. H., Frosch, M. P., & Hyman, B. T. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.02.031 · Cited by 169 · cited 1×
“However, one neuropathological study of 40 AD patients and 32 HIs revealed a phenotype change in astrocytes and microglia in AD but a constant number of these cells over the clinical course of the disease (Serrano-Pozo et al., 2013).”
BackgroundA quantitative neuropathological assessment of translocator protein expression in multiple sclerosis
Nutma, E., Stephenson, J. A., Gorter, R. P., de Bruin, J., Boucherie, D. M., Donat, C. K., Breur, M., van der Valk, P., Matthews, P. M., Owen, D. R., et al. (2019) · Brain · doi:10.1093/brain/awz287 · Cited by 138 · cited 2×
“This issue was recently addressed in a quantitative neuropathological study of patients with multiple sclerosis (Nutma et al., 2019).”
BackgroundPK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET
Venneti, S., Lopresti, B. J., Wang, G., Hamilton, R. L., Mathis, C. A., Klunk, W. E., Apte, U. M., & Wiley, C. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.005 · Cited by 138
Fan, Z., Okello, A. A., Brooks, D. J., & Edison, P. (2015) · Brain · doi:10.1093/brain/awv288 · Cited by 135
Microglial activation in early stages of amyloid β protein deposition
Sasaki, A., Yamaguchi, H., Ogawa, A., Sugihara, S., & Nakazato, Y. (1997) · Acta Neuropathologica · doi:10.1007/s004010050713 · Cited by 132 · cited 1×
“Two neuropathological studies described clustered microglia around amyloid deposits in the cerebellum, but morphological features of activation were observed only in the vicinity of compact aggregates and not around diffuse deposits (Mattiace et al., 1990; Sasaki et al., 1997).”
BackgroundBetlazar, C., Harrison-Brown, M., Middleton, R., Banati, R., & Liu, G.-J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092707 · Cited by 124 · cited 1×
“Another well-described characteristic of TSPO imaging is the ubiquitous brain expression of TSPO (Nutma et al., 2021) and especially a high endothelial expression (Betlazar et al., 2018).”
BackgroundRizzo, G., Veronese, M., Tonietto, M., Zanotti-Fregonara, P., Turkheimer, F. E., & Bertoldo, A. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.55 · Cited by 121
[ 11 C]PK11195 binding in Alzheimer disease and progressive supranuclear palsy
Passamonti, L., Rodríguez, P. V., Hong, Y. T., Allinson, K. S. J., Bevan-Jones, W. R., Williamson, D., Jones, P. S., Arnold, R., Borchert, R. J., Surendranathan, A., et al. (2018) · Neurology · doi:10.1212/wnl.0000000000005610 · Cited by 115
Sifting through the surfeit of neuroinflammation tracers
Cumming, P., Burgher, B., Patkar, O., Breakspear, M., Vasdev, N., Thomas, P., Liu, G.-J., & Banati, R. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17748786 · Cited by 111 · cited 3×
“Several TSPO radiotracers have been used over the past two decades, such as [11C]-PK11195 and a second generation of compounds including [11C]-PBR28, [11C]-ER176, [18F]-GE-180, [18F]-GE-387, and [18F]-DPA714, among others (Cumming et al., 2018; Qiao et al., 2019).”
BackgroundMethodPannell, M., Economopoulos, V., Wilson, T. C., Kersemans, V., Isenegger, P. G., Larkin, J. R., Smart, S., Gilchrist, S., Gouverneur, V., & Sibson, N. R. (2020) · Glia · doi:10.1002/glia.23716 · Cited by 109
Microglia in cerebellar plaques in Alzheimer's disease
Mattiace, L. A., Davies, P., Yen, S. H., & Dickson, D. W. (1990) · Acta Neuropathologica · doi:10.1007/bf00294609 · Cited by 109 · cited 1×
“Two neuropathological studies described clustered microglia around amyloid deposits in the cerebellum, but morphological features of activation were observed only in the vicinity of compact aggregates and not around diffuse deposits (Mattiace et al., 1990; Sasaki et al., 1997).”
BackgroundMolecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment
Knezevic, D., & Mizrahi, R. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.05.007 · Cited by 97 · cited 1×
“IMAGING IN ALZHEIMER ’S DISEASE: AN UPDATE The results of TSPO imaging in AD were widely reviewed up until 2018–2019 by several expert groups (Chandra et al., 2019; Edison & Brooks, 2018; Knezevic & Mizrahi, 2018; Kreisl et al., 2020; Lagarde et al., 2018).”
BackgroundGulyás, B., Vas, Á., Tóth, M., Takano, A., Varrone, A., Cselényi, Z., Schain, M., Mattsson, P., & Halldin, C. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.02.020 · Cited by 94
Neocortical Glial Cell Numbers in Alzheimer’s Disease
Pelvig, D. P., Pakkenberg, H., Regeur, L., Oster, S., & Pakkenberg, B. (2003) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000072805 · Cited by 81 · cited 1×
“Another postmortem stereological study of 14 AD cases and 20 HIs showed no increase in the total number of neocortical glial cells in AD (Pelvig et al., 2003).”
BackgroundNarayan, N., Mandhair, H., Smyth, E., Dakin, S. G., Kiriakidis, S., Wells, L., Owen, D., Sabokbar, A., & Taylor, P. (2017) · PLOS ONE · doi:10.1371/journal.pone.0185767 · Cited by 79 · cited 1×
“Another study revealed that pro-inflammatory stimulation elicits a dose-dependent decrease in tspo mRNA and TSPO levels in the macrophages of patients with rheumatoid arthritis, whereas anti-inflammatory stimulation produces no change in TSPO levels (Narayan et al., 2017).”
BackgroundVeronese, M., Reis Marques, T., Bloomfield, P. S., Rizzo, G., Singh, N., Jones, D., Agushi, E., Mosses, D., Bertoldo, A., Howes, O., et al. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17712388 · Cited by 65
Impact of Endothelial 18-kDa Translocator Protein on the Quantification of18F-DPA-714
Wimberley, C., Lavisse, S., Brulon, V., Peyronneau, M.-A., Leroy, C., Bodini, B., Remy, P., Stankoff, B., Buvat, I., & Bottlaender, M. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.195396 · Cited by 63
Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study
Parbo, P., Ismail, R., Sommerauer, M., Stokholm, M. G., Hansen, A. K., Hansen, K. V., Amidi, A., Schaldemose, J. L., Gottrup, H., Brændgaard, H., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.06.004 · Cited by 63
In Vivo Assessment of Neuroinflammation in 4‐Repeat Tauopathies
Palleis, C., Sauerbeck, J., Beyer, L., Harris, S., Schmitt, J., Morenas‐Rodriguez, E., Finze, A., Nitschmann, A., Ruch‐Rubinstein, F., Eckenweber, F., et al. (2021) · Movement Disorders · doi:10.1002/mds.28395 · Cited by 62 · cited 1×
“Clinical TSPO imaging recently provided substantial descriptions of the role of neuroinflammation in several neurological disorders, such as frontotemporal and Lewy body dementia, as well as semantic dementia (Kreisl et al., 2020; Palleis et al., 2021; Pascual et al., 2021).”
BackgroundProspects and challenges of imaging neuroinflammation beyond TSPO in Alzheimer’s disease
Faculty, O. B. O. T. M., Boche, D., Gerhard, A., & Rodriguez-Vieitez, E. (2019) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-019-04462-w · Cited by 55 · cited 1×
“Although the development of PET tracers to explore neuroinflammation is rapidly evolving (Boche et al., 2019), the translocator protein (TSPO) remains the most common target used in neurological diseases (Kreisl et al., 2020).”
BackgroundThe hGFAP-driven conditional TSPO knockout is protective in a mouse model of multiple sclerosis
Daugherty, D. J., Chechneva, O., Mayrhofer, F., & Deng, W. (2016) · Scientific Reports · doi:10.1038/srep22556 · Cited by 36 · cited 1×
“However, this interpretation remains unclear, as several studies have shown that steroidogenesis was unchanged in TSPO knock-out mice that were healthy or in models of multiple sclerosis (Banati et al., 2014; Daugherty et al., 2016; Tu et al., 2016).”
ResultKunkle, B., Grenier-Boley, B., Sims, R., Bis, J., Naj, A., Boland, A., Vronskaya, M., van der Lee, S., Amlie-Wolf, A., Bellenguez, C., et al. (2018) · doi:10.1101/294629 · Cited by 35
Trincavelli, M. L., Marselli, L., Falleni, A., Gremigni, V., Ragge, E., Dotta, F., Santangelo, C., Marchetti, P., Lucacchini, A., & Martini, C. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10035 · Cited by 34 · cited 1×
“Reactive oxygen species and proinflammatory mediators can stimulate TSPO transcription and expression (Kruczek et al., 2009; Trincavelli et al., 2002).”
Background
Cited by
Hallmarks of neurodegenerative diseases
Wilson, D. M., Cookson, M. R., Van Den Bosch, L., Zetterberg, H., Holtzman, D. M., & Dewachter, I. (2023) · Cell · doi:10.1016/j.cell.2022.12.032 · Cited by 1,789
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Jung, H. N., Lee, S.-Y., Lee, S., Youn, H., & Im, H.-J. (2022) · Theranostics · doi:10.7150/thno.77259 · Cited by 282
Alzheimer's disease drug development pipeline: 2025
Cummings, J. L., Zhou, Y., Lee, G., Zhong, K., Fonseca, J., Leisgang‐Osse, A. M., & Cheng, F. (2025) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.70098 · Cited by 190
Metadata
- Authors
- Gouilly, D., Saint‐Aubert, L., Ribeiro, M., Salabert, A., Tauber, C., Péran, P., Arlicot, N., Pariente, J., & Payoux, P.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2022-02-10
- Volume
- 55
- Issue
- 5
- Pages
- 1322-1343
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W4210281487
- Cited by
- 63
- References
- 57
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.